ISSN 1671-5411 CN 11-5329/R

Dear Colleagues,

Journal of Geriatric Cardiology (J Geriatr Cardiol, JGC) will launch a new website and adopt ScholarOne ManuscriptsTM system to manage the submission and peer review process from November 1, 2020. To review and check the status of your manuscripts submitted before November 2020, please visit...

more

Volume 17 Issue 12
Dec.  2020
Turn off MathJax
Article Contents
Zhuang TIAN, Chao REN, Li HUO, Xiao LI, Yi-Ning WANG, Lun HUANG, Ran TIAN, Shu-Yang ZHANG. Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly. J Geriatr Cardiol 2020; 17(12): 793-796. doi: 10.11909/j.issn.1671-5411.2020.12.010
Citation: Zhuang TIAN, Chao REN, Li HUO, Xiao LI, Yi-Ning WANG, Lun HUANG, Ran TIAN, Shu-Yang ZHANG. Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly. J Geriatr Cardiol 2020; 17(12): 793-796. doi: 10.11909/j.issn.1671-5411.2020.12.010

Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly

doi: 10.11909/j.issn.1671-5411.2020.12.010
More Information
  • loading
  • [1]
    Rapezzi C, Merlini G, Quarta CC, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 2009; 120: 1203-1212. doi: 10.1161/CIRCULATIONAHA.108.843334
    [2]
    Maurer MS, Bokhari S, Damy T, et al. Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ Heart Fail 2019; 12: e006075.
    [3]
    Mohammed SF, Mirzoyev SA, Edwards WD, et al. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2014; 2: 113-122. doi: 10.1016/j.jchf.2013.11.004
    [4]
    González-López E, Gallego-Delgado M, Guzzo-Merello G, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 2015; 36: 2585-2594. doi: 10.1093/eurheartj/ehv338
    [5]
    Yamamoto H, Yokochi T. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment. ESC Heart Fail 2019; 6: 1128-1139. doi: 10.1002/ehf2.12518
    [6]
    Phelan D, Thavendiranathan P, Popovic Z, et al. Application of a parametric display of two-dimensional speckle-tracking longitudinal strain to improve the etiologic diagnosis of mild to moderate left ventricular hypertrophy. J Am Soc Echocardiogr 2014; 27: 888-895. doi: 10.1016/j.echo.2014.04.015
    [7]
    Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005; 111: 186-193. doi: 10.1161/01.CIR.0000152819.97857.9D
    [8]
    Singh V, Falk R, Di Carli MF, et al. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J Nucl Cardiol 2019; 26: 158-173. doi: 10.1007/s12350-018-01552-4
    [9]
    Bokhari S, Castaño A, Pozniakoff T, et al. 99mTC-Pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 2013; 6: 195-201. doi: 10.1161/CIRCIMAGING.112.000132
    [10]
    Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 2016; 133: 2404-2412. doi: 10.1161/CIRCULATIONAHA.116.021612
    [11]
    Maurer MS, Schwartz JH, Gundapaneni B, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 2018; 379: 1007-1016. doi: 10.1056/NEJMoa1805689
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)

    Article Metrics

    Article views (40) PDF downloads(4) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return